Navigation path

Pharmaceuticals - Community Register


Community list of not active veterinary medicinal products


Product information

Invented name: Nobilis Influenza H7N1
Auth. number : EU/2/07/073
Active substance : Inactivated whole avian influenza virus antigen of H7N1 subtype (strain, A/CK/Italy/473/99), inducing an HI titre of ≥6.0 log2 as tested according to the potency test.
ATC: Anatomical main group: QI - Immunologicals
Therapeutic subgroup: QI01 - Immunologicals for aves
Pharmacological subgroup: QI01A - Domestic fowl
Chemical subgroup: QI01AA - Inactivated viral vaccines
Chemical substance: QI01AA23 - avian influenza virus
(See WHO ATCvet Index)
Indication: For active immunisation of chickens and ducks against avian influenza type A, subtype H7
Marketing Authorisation Holder: Intervet International B.V.
Wim de Körverstraat 35, 5831 AN Boxmeer, Nederland
EPAR and active package presentations

Package presentations

Information about presentations can be found in the website of the European Medicines Agency under the section "Product Information".
Likewise, presentations on which there has been a Commission decision are referred in the Summary of Product Characteristics (Annex I to the Commission Decision granting the marketing authorisation) which is available in the Community Register.

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
16/05/2007 Centralised - Authorisation EMEA/V/C/123 (2007)2167 of 14/05/2007
10/04/2008 Centralised - Variation EMEA/V/C/123/IB/2
Updated with Decision(2008)3229 of 23/06/2008
25/06/2008 Centralised - Annual reassessment EMEA/V/C/123/S/1 (2008)3229 of 23/06/2008
4/08/2009 Centralised - Annual reassessment EMEA/V/C/123/S/3 (2009)6240 of 31/07/2009
9/07/2010 Centralised - Withdrawal (2010)4836 of 7/07/2010